EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)

Calculates EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) across 12 domains to assess systemic involvement and eligibility for hydroxychloroquine, rituximab, or belimumab therapy.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculates EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) across 12 domains to assess systemic involvement and eligibility for hydroxychloroquine, rituximab, or belimumab therapy

Each component has a specific meaning:

  • 12 domains — The 12 domains recorded for the patient or scenario being assessed.

Note: Interpret the essdai score result against the clinical thresholds and context described above.

How to Use

Enter the 12 domains for the patient or scenario you are assessing. Calculates EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) across 12 domains to assess systemic involvement and eligibility for hydroxychloroquine, rituximab, or belimumab therapy. Use the essdai score result to inform your clinical assessment.

Frequently Asked Questions